Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity

Objectives: This study tested the hypothesis that a differential innate immune antimicrobial peptide (AMP) profile was evident between the skin and joints in psoriasis and psoriatic arthritis (PsA) and that PsA synovitis may have a distinct AMP pattern compared to other arthropathies. Method: Twenty-two cases had knee biopsies [10 PsA, eight rheumatoid arthritis (RA), and four osteoarthritis (OA)]. Lesional and non-lesional skin biopsies in psoriasis and control tissue were also obtained (n = 4 each). Immunohistochemistry with semi-quantitative scoring of both synovium and skin was performed using the following panel of AMPs: S100 A8, S100 A9, human neutrophil peptides 1–3 (HNP1–3), human β-defensins 2 and 3 (hBD-2 and hBD-3), cathelicidin LL-37, psoriasin (S100 A7), and ribonuclease 7 (RNase 7). Results: Similar expression of S100 A8, S100 A9, and HNP1–3 was detectable in PsA and RA synovium but only in the synovium sublining layer (SSL). No expression of psoriasin, RNase 7, hBD-2, and hBD-3 could be detected in the synovial tissue of PsA, RA, or OA. All psoriasis skin samples exhibited broad expression of all investigated AMPs, with strong keratinocyte expression. Conclusions: Given that some AMPs, especially hBD-2, are genetically linked to psoriasis and are only expressed in the skin, these findings show how differential AMP expression in innate immune responses may contribute to disease heterogeneity between PsA and psoriasis and provides a genetic basis for the non-progression of psoriasis subgroups to PsA.

[1]  M. Gilliet,et al.  Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self‐DNA , 2015, European journal of immunology.

[2]  M. Wittmann,et al.  Cytokines as therapeutic targets in skin inflammation. , 2014, Cytokine & growth factor reviews.

[3]  C. Eriksson,et al.  S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis , 2014, Journal of immunology research.

[4]  J. Szepietowski,et al.  The New Insight into the Role of Antimicrobial Proteins-Alarmins in the Immunopathogenesis of Psoriasis , 2014, Journal of immunology research.

[5]  B. Kirkham,et al.  Interleukin-17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression , 2014, Arthritis & rheumatology.

[6]  Raquel Navarro,et al.  S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. , 2013, Immunity.

[7]  R. Hancock,et al.  Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. , 2013, Nature chemical biology.

[8]  P. Emery,et al.  The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development , 2012, Annals of the rheumatic diseases.

[9]  K. Bornfeldt,et al.  Novel insights into the role of S100A8/A9 in skin biology , 2012, Experimental dermatology.

[10]  Liliane Schoofs,et al.  A comprehensive summary of LL-37, the factotum human cathelicidin peptide. , 2012, Cellular immunology.

[11]  M. McDermott,et al.  The early phase of psoriatic arthritis , 2011, Annals of the rheumatic diseases.

[12]  U. Mrowietz,et al.  Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. , 2010, The Journal of investigative dermatology.

[13]  J. Gudjonsson,et al.  Psoriasis--as an autoimmune disease caused by molecular mimicry. , 2009, Trends in immunology.

[14]  D. Foell,et al.  The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer , 2009, Journal of leukocyte biology.

[15]  J. Schröder,et al.  RNase 7 Contributes to the Cutaneous Defense against Enterococcus faecium , 2009, PloS one.

[16]  T. Pufe,et al.  The antimicrobial peptide HBD-2 and the Toll-like receptors-2 and -4 are induced in synovial membranes in case of septic arthritis , 2009, Virchows Archiv.

[17]  Andrea W. M. Evers,et al.  β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin , 2009, PloS one.

[18]  Gonçalo Abecasis,et al.  Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis , 2009, Nature Genetics.

[19]  E J Hollox,et al.  Copy number variation of beta-defensins and relevance to disease , 2009, Cytogenetic and Genome Research.

[20]  W. Nacken,et al.  Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis , 2007, Annals of the rheumatic diseases.

[21]  André Reis,et al.  Psoriasis is associated with increased beta-defensin genomic copy number. , 2008, Nature genetics.

[22]  I. Mellman,et al.  Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide , 2007, Nature.

[23]  L. Fouser,et al.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.

[24]  G. Burmester,et al.  Synovitis score: discrimination between chronic low‐grade and high‐grade synovitis , 2006, Histopathology.

[25]  T. Pufe,et al.  Expression and regulation of antimicrobial peptides in articular joints. , 2005, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[26]  Friedrich Paulsen,et al.  Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors. , 2005, Arthritis and rheumatism.

[27]  J. Schröder,et al.  Psoriatic scales: a promising source for the isolation of human skin‐derived antimicrobial proteins , 2005, Journal of leukocyte biology.

[28]  D. Foell,et al.  Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis , 2005, Arthritis research & therapy.

[29]  J. Schröder,et al.  Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection , 2005, Nature Immunology.

[30]  R. Lehrer,et al.  Primate defensins , 2004, Nature Reviews Microbiology.

[31]  B. Bresnihan,et al.  Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. , 2003, Arthritis and rheumatism.

[32]  T. Pufe,et al.  Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes , 2002, The Journal of pathology.

[33]  M. Frosch,et al.  Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. , 1999, The Journal of rheumatology.

[34]  P. Emery,et al.  Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[35]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[36]  F. Epstein,et al.  Rheumatoid arthritis. Pathophysiology and implications for therapy. , 1990, The New England journal of medicine.